(NYSE: GSK) Gsk's forecast annual revenue growth rate of 4.92% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Gsk's revenue in 2024 is $38,389,873,417.On average, 4 Wall Street analysts forecast GSK's revenue for 2024 to be $160,993,246,440,000, with the lowest GSK revenue forecast at $160,442,502,480,000, and the highest GSK revenue forecast at $161,877,231,360,000. On average, 4 Wall Street analysts forecast GSK's revenue for 2025 to be $170,251,561,272,000, with the lowest GSK revenue forecast at $167,767,151,760,000, and the highest GSK revenue forecast at $172,564,750,800,000.
In 2026, GSK is forecast to generate $179,886,366,192,000 in revenue, with the lowest revenue forecast at $173,014,439,520,000 and the highest revenue forecast at $186,405,039,600,000.